Swiss to share H1N1 vaccines

The Swiss government has said it will participate in a United States-led programme to provide vaccines against the A/H1N1 virus to developing countries.

This content was published on September 18, 2009 - 16:18

On Friday, the Federal Health Office announced it had purchased 13 million doses against the virus, commonly known as swine flu, from drug makers Novartis and GlaxoSmithKline.

The vaccine sharing plan, initiated by the United States, will make at least ten per cent of doses available to the World Health Organization (WHO) for poor countries.

"Developing countries should be supplied with vaccines in parallel with industrialised countries," the Health Office said in a statement.

Switzerland has pledged $4.8 million (SFr5 million) to procure the vaccines and is in negotiations with producers, it said.

Australia, Brazil, France, Italy, New Zealand, Norway, and Britain are also participating in the programme.

The WHO said on Friday that vaccine production would be "substantially less" than the 4.9 billion doses previously forecast. Weekly production will be less than 94 million doses, a WHO spokesman said. and agencies

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Sort by

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Discover our weekly must-reads for free!

Sign up to get our top stories straight into your mailbox.

The SBC Privacy Policy provides additional information on how your data is processed.